Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Memantine-associated reversal of clozapine-induced weight gain
135 NakamuraK.ItohK.SugimotoT.FushikiS
By upregulating CDH13 expression, THC may promote the restoration of synaptic integrity and adaptive plasticity, thereby counteracting the detrimental effects of chronic stress and systemic inflammation on neural circuit function
Reported Side Effects: Injection site reactions (most common) Headache Mild water retention Transient dizziness Fatigue (temporary) Joint stiffness (with GH elevation) Rare/Serious (requiring immediate attention): Significant swelling of hands, feet, or face Chest pain or shortness of breath Vision changes Allergic reactions FDA Concerns: Immunogenicity risk Limited clinical safety data Classified as Category 2 bulk drug substance presenting significant safety risks Regulatory Status United States: Not FDA approved for any indication
US$ 29.79
US$ 25.73
US$ 28.96
US$ 22.64
US$ 25.69
US$ 26.05